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Obtaining drug plasma levels above theMIC for
a sufﬁcient period of time is critical for b-lactams to
effect optimal activity. For carbapenems, a target
exposure of 25–40% T > MIC is considered sufﬁ-
cient to achieve signiﬁcant antibacterial activity
[9,10]. Both of the treatment regimens used in the
present study maintained drug plasma levels
above the MIC for >30% of the time for all three
imipenem-susceptible isolates. By meeting this
requirement, imipenem produced an antibacterial
effect on the susceptible control isolate that is
maximal in thismodel [7]. Despite these favourable
pharmacokinetic parameters, imipenem had infer-
ior activity against the VPKP isolates. The antibac-
terial effect of the drug on the two susceptible
VPKP isolates was signiﬁcantly augmented by
doubling the dosage, as has also been reported for
aztreonam in an experimental rat model of
pneumonia caused by VIM-1-producing Pseudo-
monas aeruginosa [11]. Nevertheless, imipenem
activity remained lower than that obtained
against the susceptible control. A possible explan-
ation for the low-to-moderate activity of imipenem
against the susceptible VPKP isolates is the opera-
tion of an in-vivo inoculum effect, similar to that
observed in vitro. While the present data cannot
provide ﬁrm conclusions regarding the treatment
of infections caused by VPKP strains with imipe-
nem MICs in the susceptible range, they clearly
suggest that the administration of imipenem at
higher doses may prove to be of some beneﬁt.
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ABSTRACT
Risk-factors for bacteraemia were determined in a
case-control study of patients with Escherichia coli
urinary tract infection. Cases were deﬁned as
patients with E. coli urinary source bacteraemia,
and controls were chosen from among patients
with E. coli urinary tract infection without bacter-
aemia. Patient characteristics were collected
prospectively and the bacterial traits were deter-
mined. The phylogenetic background and viru-
lence factors of E. coli isolates did not differ
between cases and controls. In multivariate
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analysis, being female and having a urinary
catheter were signiﬁcantly less prevalent among
patients with urinary source bacteraemia than
among patients with uncomplicated urinary tract
infection.
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Extra-intestinal infections caused by Escherichia
coli, such as urinary tract infections and bacterae-
mia, are a major cause of morbidity, mortality and
increased costs for hospital treatment [1,2]. The
virulence genotype and phylogenetic background
have been correlated with the pathogenicity of
E. coli strains responsible for extra-intestinal
infections [2–4]. E. coli strains fall into four main
phylogenetic groups (A, B1, B2 and D) [5], with
virulent extra-intestinal strains belonging primar-
ily to group B2 and, to a lesser extent, group D,
whereas most commensal strains belong to
groups A and B1 [6]. The role of virulence traits
and phylogenetic background in the pathogenesis
of urinary source bacteraemia (USB) is not com-
pletely understood. Moreover, patient character-
istics, such as the underlying disease and the type
of care, e.g., the use of an invasive device or
antimicrobial treatment, are likely to be involved.
This study investigated the determinants
involved in the occurrence of E. coli USB at the
University Hospital, Besanc¸on, France.
Between 1 October 2002 and 1 March 2003, 28
patients with clinical signs of bacteraemia yielded
E. coli from both blood and urine. Of these, 24
were included for analysis in the present study,
comprising patients with E. coli bacteraemia
caused by a strain with a similar pulsed-ﬁeld gel
electrophoresis (PFGE) pattern to that of the strain
isolated from the UTI. Controls were chosen from
among patients with E. coli UTI, but without
bacteraemia. Controls were chosen from the same
unit as the cases, and were paired with cases
according to their antimicrobial resistance pat-
tern.
The multiplex PCR technique described by
Clermont et al. [7] was used to categorise the
E. coli isolates into one of the four principal E. coli
phylogenetic groups (A, B1, B2 or D). All isolates
were tested for seven E. coli virulence genes using
multiplex PCR [8], i.e., papC, papEF, sfa, afa, hly, aer
and cnf. Patient characteristics were also recorded.
Univariate and multivariate statistical analysis
were performed using Systat software v.8.0 (SPSS
Inc., Chicago, IL, USA) and LogXact software
(CYTEL Software Corp., Cambridge, MA, USA).
The 24 cases were paired with 46 controls (22
cases were paired with two controls each, and two
cases with one control each). Cases were not
signiﬁcantly older than controls (p 0.25), with
a mean age of 71.0 ± 15.8 years and 64.5 ±
26.8 years, respectively. Patient characteristics
are listed in Table 1. Univariate analysis revealed
that cases were signiﬁcantly more often male than
were controls (p 0.01). None of the other charac-
teristics recorded was associated with bacterae-
mia. The number of virulence genes did not differ
signiﬁcantly between cases and controls, with an
average of 2.0 ± 1.6 and 1.84 ± 1.6 virulence
genes, respectively (p 0.70). Four variables with
a p value £0.2 in the univariate analysis were
introduced into the multivariate model, i.e., gen-
der, alcoholism, presence of a urinary catheter
device, and presence of the hly virulence gene.
The ﬁnal multivariate model revealed that being
female (p 0.005) and having a urinary catheter
(p 0.019) were linked with fewer cases of bacter-
aemia secondary to E. coli UTI.
There are few data available concerning the
virulence characteristics of E. coli isolates from
patients with USB, or concerning the association
between molecular determinants and invasive-
ness in this condition. Therefore, the virulence
characteristics and phylogenetic background of
E. coli isolates causing USB were assessed and
compared with those of E. coli isolates responsible
for non-bacteraemic UTI. No signiﬁcant differ-
ences in bacterial determinants were revealed
between these two types of isolates. These results
are concordant with those of Bonacorsi et al. [9].
In contrast, Moreno et al. [10] reported that the
virulence genes sfa and cnf were signiﬁcantly
more prevalent among isolates causing USB than
among isolates causing pyelonephritis with a
negative blood culture. This discrepancy may be
related to the case mix and inclusion design.
Thus, in the present study, age and frequency of
the underlying disease were similar for cases and
controls, whereas there was a large difference in
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age between the two groups of patients in the
study by Moreno et al. [10]. In addition, in
contrast to Moreno et al. [10], the present study
checked speciﬁcally that the isolates from blood
and urine were identical. Using PFGE, it was
shown that most (85.7%; 24 of 28) isolates from
blood were identical to the corresponding isolates
from urine. Previous studies have reported sim-
ilar ﬁndings [11,12].
Female gender and the presence of a urinary
catheter were associated with fewer cases of E. coli
bacteraemia once the bacteria have infected the
urinary tract. A urinary catheter bypasses the
normal host defences and allows the entry of
pathogens into the bladder. The presence of a
foreign body also leads to the formation of a
bioﬁlm, which helps pathogens to proliferate and
cause infection. Because of the different mecha-
nisms involved in infection, the E. coli isolates
responsible for catheter-associated UTI harbour
fewer virulence factors than isolates causing
classical UTI [13]. It is likely that these isolates
are less invasive, and are thus less able to invade
the bloodstream once they have infected the
urinary tract.
There were some limitations to the present
study. First, only a limited number of virulence
genes were characterised, and it is possible that
other known virulence factors [14,15] may also be
involved in bloodstream invasion. However,
studies including additional risk-factors (e.g.,
ibeA, malX or kspM II) have also failed to reveal
an association between these factors and the
invasiveness of the strains studied [13,14]. Sec-
ond, the diagnosis of bacteraemia in symptomatic
UTI depends on the time at which blood cultures
are taken, and a positive blood culture may not be
a clear-cut factor that allows discrimination.
Nevertheless, the ﬁndings suggest that E. coli
strains of urinary tract origin, which also cause
bacteraemia, do not differ signiﬁcantly from those
responsible for UTI only, with respect to their
phylogenetic background and virulence determi-
nants. These data should be conﬁrmed by
Table 1. Comparison between cases
(patients with Escherichia coli urinary
source bacteraemia) and controls
(patients with E. coli urinary tract








n (%) OR 95% CI p
Patient characteristics
Male 10 (41.6) 5 (10.8) 5.69 1.47–25.15 0.01
Underlying diseases 13 (54.2) 19 (41.3) 1.67 0.55–5.11 0.44
Cancer 4 (16.7%) 5 (10.8%) 1.62 0.28–8.50 0.73
Diabetes 4 (16.7%) 7 (15.2%) 1.10 0.21–5.02 0.90
Renal insufﬁciency 2 (8.3%) 5 (10.8%) 0.79 0.07–4.80 0.80
Hepatic insufﬁciency 1 (4.2%) 1 (2.2%) 2.00 0.12–31.9 0.62
Alcoholism 4 (16.7%) 1 (2.2%) 7.12 0.79–64.3 0.08
Cardiac insufﬁciency 3 (12.5%) 5 (10.8%) 1.16 0.16–6.70 0.89
Respiratory insufﬁciency 2 (8.3%) 2 (6.5%) 1.29 0.10–12.21 0.99
Immunodeﬁciency 5 (20.8%) 5 (15.2%) 1.77 0.39–8.03 0.46
Transplant 3 (12.5%) 3 (6.5%) 2.02 0.25–196.4 0.67
AIDS 0 (0.0%) 0 (0.0%) – – –
Pregnancy 1 (4.2%) 1 (2.2%) 1.93 0.02–1.56 0.99
Corticosteroids 1 (4.2%) 3 (6.5%) 0.63 0.01–8.31 0.99
Invasive device 2 (8.3%) 13 (28.3%) 0.23 0.02–1.19 0.09
Peripheral vascular catheter 0 (0.0%) 3 (6.5%) 0.48 0.00–4.64 0.55
Central vascular catheter 0 (0.0%) 2 (4.4%) 0.78 0.00–10.25 0.86
Urinary catheter 2 (8.3%) 12 (26.1%) 0.26 0.03–1.35 0.14
Invasive respiratory device 0 (0.0%) 2 (4.4%) 0.78 0.00–10.25 0.85
Antibiotic treatment before UTI 3 (12.5%) 8 (17.4%) – – 0.79
E. coli characteristics
Phylogenetic group
Group A 3 (12.5%) 9 (19.6%) – –
Group B1 3 (12.5%) 4 (8.7%) – – 0.53
Group B2 12 (50.0%) 27 (58.7%) – –
Group D 6 (25.0%) 6 (13.0%) – –
Virulence genes
papC 14 (58.3%) 20 (43.5%) 1.80 0.59–5.60 0.26
papEF 15 (62.5%) 26 (56.5%) 1.28 0.41–4.05 0.82
sfa 5 (20.8%) 10 (21.7%) 0.94 0.22–3.60 0.99
afa 2 (8.3%) 6 (13.0%) 0.61 0.05–3.79 0.87
hly 5 (20.8%) 4 (8.7%) 2.71 0.52–15.3 0.20
aer 1 (4.2%) 4 (8.7%) 0.50 0.01–5.05 0.87
cnf 6 (25.0%) 15 (32.6%) 0.69 0.18–2.32 0.70
TI, urinary tract infection.
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additional studies, but factors other than bacterial
virulence are probably more important in the
development of a symptomatic UTI into USB.
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ABSTRACT
Isolates of Escherichia coli from 31 Norwegian and
31 Russian females with signiﬁcant bacteruria
who presented with clinical signs of urinary tract
infection (UTI) were tested for antimicrobial
sensitivity, the presence of virulence genes, phy-
logroup distribution and clonal afﬁnity. Twenty
isolates, representing the full clonal diversity of a
collection of 138 intestinal isolates of E. coli from
healthy Norwegian females, served as a reference
group. Russian UTI isolates belonged more often
to phylogroup A and possessed fewer virulence
genes than did Norwegian isolates. UTI isolates of
E. coli were genetically heterogeneous and had a
high degree of antimicrobial sensitivity.
Keywords Antimicrobial sensitivity, clonal diversity,
Escherichia coli, phylogenetic groups, urinary tract
infection, virulence factors
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